Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
7 Jan 25 | NAMS NewAmsterdam Pharma | Ordinary Shares | Grant | Acquire A | No | No | 0 | 6,960 | 0.00 | 6,960 |
6 Jan 25 | NAMS NewAmsterdam Pharma | Option Ordinary Shares | Grant | Acquire A | No | No | 25.85 | 32,500 | 840.13 k | 32,500 |
1 Aug 24 | GNLX Genelux | Common Stock | Grant | Acquire A | No | No | 0 | 39,541 | 0.00 | 52,711 |
1 Aug 24 | GNLX Genelux | Stock Option Right to Buy) Common Stock | Grant | Acquire A | No | No | 1.96 | 50,469 | 98.92 k | 50,469 |
29 May 24 | GNLX Genelux | Common Stock | Buy | Acquire P | No | No | 0 | 6,250 | 0.00 | 13,170 |
29 May 24 | GNLX Genelux | Common Stock Warrant Common Stock | Buy | Acquire P | No | No | 5.25 | 6,250 | 32.81 k | 6,250 |
13 Feb 24 | ARQT Arcutis Biotherapeutics | Common Stock | Grant | Acquire A | No | No | 0 | 8,572 | 0.00 | 11,365 |
13 Feb 24 | ARQT Arcutis Biotherapeutics | Common Stock | Grant | Acquire A | No | No | 0 | 2,793 | 0.00 | 2,793 |
13 Feb 24 | ARQT Arcutis Biotherapeutics | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 32.44 | 25,718 | 834.29 k | 0 |
13 Feb 24 | ARQT Arcutis Biotherapeutics | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 27.61 | 8,379 | 231.34 k | 0 |